People and Places

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 16 No 3
Volume 16
Issue 3

Dr. Richard Schilsky, Dr. Edward Pan, Pam Kedziera

Dr. Richard Schilsky

Richard L. Schilsky, MD, associate dean for clinical research at the University of Chicago Pritzker School of Medicine, has been elected president of the American Society of Clinical Oncology for the 2008-2009 term. He will be inducted as president-elect at ASCO's 43rd Annual Meeting in June 2007. Dr. Schilsky's interests include GI cancers, cancer pharmacology, and drug development.

Dr. Edward Pan

The Orlando campus of M.D. Anderson has added neuro-oncologist Edward Pan, MD, to its staff. Dr. Pan comes to M.D. Anderson from the Florida Hospital Cancer Institute where he was co-medical director of neuro-oncology. Prior to that appointment, he was on faculty as a clinical instructor for the Brain Tumor Research Center at the University of California, San Francisco.

Pam Kedziera

Fox Chase Cancer Center has named Pam Kedziera, RN, MSN, ACON, as clinical director of the center's pain and palliative care program. In her new role, she will help lead expansion of the pain management center into a broader focused program while continuing to direct the staff and programs offered at the center. Ms. Kedziera has been affiliated with Fox Chase since 1980.

Recent Videos
Experts from Vanderbilt University Medical Center emphasize gathering a second opinion to determine if a tumor is resectable in patients with pancreatic cancer.
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
Experts from Vanderbilt University Medical Center discuss the use of intraoperative radiation therapy in a 64-year-old patient with pancreatic cancer.
Balazs Halmos, MD, with the Oncology Brothers presenting slides
Balazs Halmos, MD, with the Oncology Brothers presenting slides
Balazs Halmos, MD, with the Oncology Brothers presenting slides
Balazs Halmos, MD, with the Oncology Brothers presenting slides
Balazs Halmos, MD, with the Oncology Brothers presenting slides
Although no responses were observed in 11 patients receiving abemaciclib monotherapy, combination therapies with abemaciclib may offer clinical benefit.
Related Content